ClinicalTrials.gg
CompletedNCT05779839Updated Oct 19, 2026

A Study of Caregiver Connections Via Technology in Dementia

An interventional study of Algorithm and Random Match in Caregiver Stress, Dementia and Alzheimer Disease, sponsored by Mayo Clinic. Completed at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-19.

Sponsored by Mayo Clinic · Not applicable, Interventional, and Supportive care

How we know

Updated Oct 19, 2026Now CompletedStart date moved+3 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
420
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 228 studies in Caregiver Burden with a site in United States — 59 open to participants now, 71 under way, 1 of them phase 3. Caregiver Burden · United States.

Enrollment
13th of 208
420 · median 60
Started
2023
with 32 others
No phase
190 of 228
50 open now
Registered
128th of 228
by date

Among the 228 studies in Caregiver Burden with a site in United States, this one is the 13th largest by enrollment of the 208 interventional ones that give a count, is one of 33 that started in 2023, is one of 190 with no phase, and was the 128th registered.

Caregiver Burden

503 studies on the registry are indexed under Caregiver Burden; 166 are open to participants now.

Browse Caregiver Burden studies →

Open to participants now

59 of the 228 studies in Caregiver Burden with a site in United States are open now. Recruiting first, the newest first:

54 more — sign in →

All 59 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 90 Caregiver Burden studies recruiting now, 69 (77%) set no upper age limit and 7 (8%) stop at 75 or younger; 8 take children under 18; 39 take healthy volunteers.

This study: 18 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 228 studies in Caregiver Burden with a site in United States, or all of them as a file.
02

Study summary

This research is being done to develop a unique matching process for caregivers of persons living with dementia, such as Alzheimer's disease, Lewy body dementia, frontotemporal degeneration, or other dementia syndromes. Dementia caregivers often assume greater caregiving burden than do non-dementia caregivers, and the caregiving duration tends to be longer. Many caregivers do not have the adequate support they need. Peer-to-peer support has been shown to improve quality of life, more engagement with services, improve caregiver health, and reduce hospitalizations in the person they are caring for. This study will help determine whether caregivers of persons with dementia would find a technology-based caregiver matching program valuable for the purpose of emotional support.

03

Conditions studied

  • Caregiver Stress
  • Dementia
  • Alzheimer Disease
  • Lewy Body Dementia
  • Parkinson Disease Dementia
  • Frontotemporal Dementia
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • The participant must have a family member that has been diagnosed with one of the following forms of dementia: Parkinson's/Lewy body dementia, any frontotemporal lobar degeneration dementia, or Alzheimer's dementia.
  • The participant must identify as a care partner or caregiver who has contact with their loved one with dementia, in person or by phone, and provides social/emotional support and full or partial assistance with daily activities at least 3 days per week.
  • The participant must have been caring for their loved one with dementia for at least 3 months.
  • All participants must have access to a computer and be able to use the internet.
  • All participants must be English speaking.
  • All participants must agree to participate in the 15-month study, which includes completing questionnaires, brief "virtual" interactions with the study coordinator quarterly, and actively interacting with the website and potential matches.
  • All participants must agree to follow-up contact throughout the duration of the study, which is anticipated to last 3 years.

Exclusion criteria

Exclusion Criteria:

  • Caregiver's loved one does not have a confirmed diagnosis of dementia.
  • Caregiver is unable to provide consent.
  • Caregiver was or has been in that role for less than 3 months.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Investigator)
Enrollment
420 participants (actual)

Study arms

  • Experimental
    Algorithmically Matched

    Individuals that identify as a current and/or former caregiver for a person with dementia will be matched to other caregivers using an algorithm that matches a caregiver to another caregiver based on specific preferences each caregiver identifies in a questionnaire.

    Behavioral: Algorithm

  • Active comparator
    Randomly Matched

    Individuals that identify as a current and/or former caregiver for a person with dementia will be randomly matched to other caregivers not based on the preferences they identified in a questionnaire.

    Behavioral: Random Match

Interventions

  • BehavioralAlgorithm

    For purpose of finding peer-to-peer support, current and/or former caregivers of persons with dementia will be matched using an algorithm. They can then choose make a connection and maintain a connection for the duration of the study.

  • BehavioralRandom Match

    For purpose of finding peer-to-peer support, current and/or former caregivers of persons with dementia will be randomly matched. They can then choose make a connection and maintain a connection for the duration of the study.

06

What researchers measure

Primary outcomes

  1. Match Satisfaction Questionnaire

    All participants will complete a match satisfaction questionnaire to assess whether being matched to a supportive caregiver via an algorithm based on personal preferences results in greater match satisfaction than being matched at random. Questions are scored from 0 to 4 with a possible total of 28. Scores are interpreted such that an overall total of: 0 - 7 = low satisfaction; 8-14 = medium/average satisfaction; 15-28 = high satisfaction

    Time frame: 12 months

  2. Change over time from Baseline Resilience to 12 months

    All participants will complete questions surveying resilience to determine whether caregivers randomized to algorithmic matching based on personal preferences will report a greater sense of resiliency after being matched than caregivers who are randomly matched.

    Time frame: Baseline, 12 months

  3. Change over time from Baseline Quality of Life to 12 months

    All participants will complete questions surveying quality of life to determine whether caregivers randomized to algorithmic matching based on personal preferences will report improved quality of life after being matched than caregivers who are randomly matched.

    Time frame: Baseline, 12 months

  4. Scale of Perceived Social Support

    All participants will complete survey questions regarding perceived level of social support to assess impact on match satisfaction.

    Time frame: 12 months

Secondary outcomes

  1. Survey of Executive Skills

    All participants will complete questions regarding executive functioning (e.g., flexibility, problem-solving) to determine whether the level of these skills relates to ease or difficulty in finding a satisfactory supportive caregiver match.

    Time frame: 12 months

07

Study locations

1 site
  • Mayo Clinic Rochester
    Rochester, Minnesota 55905, United States
08

References and documents

Individual participant data

Plan to share: No

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Feb 2023 to primary completion in Mar 2026, 37 months.

Of 285 non-industry interventional studies with no phase under Caregiver Burden, half reached primary completion within 17 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 31. This study's 37 months is above that.

Counting every sponsor, half of 294 studies reached it within 16 months; a quarter within 7 and three quarters within 31.

Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 19, 2026: primary completion Jul 2026 → Mar 2026 and completion Jul 2026 → Mar 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Feb 21, 2023
First posted
Mar 22, 2023
StartActual
Feb 6, 2023
Primary completionActual
Mar 22, 2026was Jul 2026
CompletionActual
Mar 22, 2026was Jul 2026
Last update
Oct 19, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Active, not recruiting→Completed
changed Oct 19, 2026
Start date
Feb 22, 2023→Feb 6, 2023
Oct 19, 2026
Primary completion
Jul 31, 2026→Mar 22, 2026 (actual)
Oct 19, 2026
Study completion
Jul 31, 2026→Mar 22, 2026 (actual)
Oct 19, 2026
Enrollment
355 (estimated)→420 (actual)
Oct 19, 2026
Show all 1 update
  1. Oct 19, 2026
    Active, not recruiting→Completed
    Start date Feb 22, 2023→Feb 6, 2023
    Primary completion Jul 31, 2026→Mar 22, 2026 (now actual)
    Study completion Jul 31, 2026→Mar 22, 2026 (now actual)
    Enrollment 355 (estimated)→420 (actual)
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT05779839
Lead sponsor
Mayo Clinic
Collaborators
National Institute on Aging (NIA), Minnesota HealthSolutions
Responsible party
Julie A. Fields, Ph.D., L.P. (Principal Investigator, Mayo Clinic) — Principal investigator
First posted
Mar 22, 2023
Start date
Feb 6, 2023
Primary completion
Mar 22, 2026
Completion
Mar 22, 2026
Last update
Oct 19, 2026

Study contacts

Julie Fields, PhD, LP
principal investigator · Mayo Clinic

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion